Taskar K[au] - Search Results

Year	Number of Results
1964	1
1965	1
2009	2
2010	1
2011	1
2012	1
2014	1
2016	2
2017	2
2018	2
2019	2
2020	3
2021	5
2022	6
2023	2
2024	5

1

No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches.

Nguyen D, Miao X, Taskar K, Magee M, Gorycki P, Moore K, Tai G. Nguyen D, et al. Among authors: taskar k. Pharmacol Res Perspect. 2024 Aug;12(4):e1238. doi: 10.1002/prp2.1238. Pharmacol Res Perspect. 2024. PMID: 38988092 Free PMC article.

2

Survey of Pharmaceutical Industry's Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working Group.

Rollison HE, Mitra P, Chanteux H, Fang Z, Liang X, Park SH, Costales C, Hanna I, Thakkar N, Vergis JM, Bow DAJ, Hillgren KM, Brumm J, Chu X, Hop CECA, Lai Y, Li CY, Mahar KM, Salphati L, Sane R, Shen H, Taskar K, Taub M, Tohyama K, Xu C, Fenner KS. Rollison HE, et al. Among authors: taskar k. Drug Metab Dispos. 2024 Jun 17;52(7):582-596. doi: 10.1124/dmd.123.001587. Drug Metab Dispos. 2024. PMID: 38697852

3

Development of a physiologically based pharmacokinetic model of fostemsavir and its pivotal application to support dosing in pregnancy.

Salem F, Nguyen D, Bush M, Moore KP, Mudunuru J, Stamatopoulos K, Thakkar N, Taskar KS. Salem F, et al. Among authors: taskar ks. CPT Pharmacometrics Syst Pharmacol. 2024 May 1. doi: 10.1002/psp4.13156. Online ahead of print. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38690782 Free article.

4

Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program.

Galluppi GR, Ahamadi M, Bhattacharya S, Budha N, Gheyas F, Li CC, Chen Y, Dosne AG, Kristensen NR, Magee M, Samtani MN, Sinha V, Taskar K, Upreti VV, Yang J, Cook J. Galluppi GR, et al. Among authors: taskar k. Clin Pharmacol Ther. 2024 Aug;116(2):282-288. doi: 10.1002/cpt.3245. Epub 2024 Mar 22. Clin Pharmacol Ther. 2024. PMID: 38519861 Review.

5

Physiologically-based pharmacokinetic modeling of prominent oral contraceptive agents and applications in drug-drug interactions.

Lewis GJ, Ahire D, Taskar KS. Lewis GJ, et al. Among authors: taskar ks. CPT Pharmacometrics Syst Pharmacol. 2024 Apr;13(4):563-575. doi: 10.1002/psp4.13101. Epub 2024 Jan 15. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38130003 Free PMC article.

6

Innovations, Opportunities, and Challenges for Predicting Alteration in Drug-Metabolizing Enzyme and Transporter Activity in Specific Populations.

Chothe PP, Arya V, Prasad B, Ramsden D, Taskar K. Chothe PP, et al. Among authors: taskar k. Drug Metab Dispos. 2023 Dec;51(12):1547-1550. doi: 10.1124/dmd.123.001453. Epub 2023 Sep 29. Drug Metab Dispos. 2023. PMID: 37775331 Free PMC article.

7

Physiologically based pharmacokinetic modeling for development and applications of a virtual celiac disease population using felodipine as a model drug.

Salem F, Nimavardi A, Mudunuru J, Tompson D, Bloomer J, Turner DB, Taskar KS. Salem F, et al. Among authors: taskar ks. CPT Pharmacometrics Syst Pharmacol. 2023 Jun;12(6):808-820. doi: 10.1002/psp4.12954. Epub 2023 Apr 2. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36855819 Free PMC article.

8

Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective.

Taskar KS, Yang X, Neuhoff S, Patel M, Yoshida K, Paine MF, Brouwer KLR, Chu X, Sugiyama Y, Cook J, Polli JW, Hanna I, Lai Y, Zamek-Gliszczynski M; ITC. Taskar KS, et al. Clin Pharmacol Ther. 2022 Sep;112(3):573-592. doi: 10.1002/cpt.2670. Epub 2022 Jun 22. Clin Pharmacol Ther. 2022. PMID: 35612761 Free PMC article. Review.

9

Robust physiologically based pharmacokinetic model of rifampicin for predicting drug-drug interactions via P-glycoprotein induction and inhibition in the intestine, liver, and kidney.

Asaumi R, Nunoya KI, Yamaura Y, Taskar KS, Sugiyama Y. Asaumi R, et al. Among authors: taskar ks. CPT Pharmacometrics Syst Pharmacol. 2022 Jul;11(7):919-933. doi: 10.1002/psp4.12807. Epub 2022 Jun 6. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35570332 Free PMC article.

10

Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective.

Chu X, Prasad B, Neuhoff S, Yoshida K, Leeder JS, Mukherjee D, Taskar K, Varma MVS, Zhang X, Yang X, Galetin A. Chu X, et al. Among authors: taskar k. Clin Pharmacol Ther. 2022 Sep;112(3):501-526. doi: 10.1002/cpt.2643. Epub 2022 Jun 21. Clin Pharmacol Ther. 2022. PMID: 35561140 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year